These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36253991)

  • 21. The effect of EMG biofeedback assisted pelvic floor muscle therapy on symptoms of the overactive bladder syndrome in women: A randomized controlled trial.
    Voorham JC; De Wachter S; Van den Bos TWL; Putter H; Lycklama À Nijeholt GA; Voorham-van der Zalm PJ
    Neurourol Urodyn; 2017 Sep; 36(7):1796-1803. PubMed ID: 27869312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder.
    Salatzki J; Liechti MD; Spanudakis E; Gonzales G; Baldwin J; Haslam C; Pakzad M; Panicker JN
    BJU Int; 2019 May; 123(5A):E20-E28. PubMed ID: 30552801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
    Serels SR; Toglia MR; Forero-Schwanhaeuser S; He W
    Curr Med Res Opin; 2010 Oct; 26(10):2277-85. PubMed ID: 20707767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
    Dokmeci F; Cetinkaya SE; Seval MM; Dai O
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective randomized trial comparing the use of tolterodine or weighted vaginal cones in women with overactive bladder syndrome.
    Yüce T; Dökmeci F; Çetinkaya ŞE
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():91-7. PubMed ID: 26720597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder.
    Tudor KI; Seth JH; Liechti MD; Ochulor J; Gonzales G; Haslam C; Fox Z; Pakzad M; Panicker JN
    Clin Auton Res; 2020 Feb; 30(1):61-67. PubMed ID: 30074101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroneal electrical transcutaneous neuromodulation in the home treatment of the refractory overactive bladder.
    Krhut J; Rejchrt M; Slovak M; Dvorak RV; Grepl M; Zvara P
    Int Urogynecol J; 2023 Jun; 34(6):1253-1260. PubMed ID: 36125509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of Vibegron in treating overactive bladder: A systematic review and pooled analysis of randomized controlled trials.
    Shi H; Chen H; Zhang Y; Cui Y
    Neurourol Urodyn; 2020 Jun; 39(5):1255-1263. PubMed ID: 32421908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men.
    De Nunzio C; Brucker B; Bschleipfer T; Cornu JN; Drake MJ; Fusco F; Gravas S; Oelke M; Peyronnet B; Tutolo M; van Koeveringe G; Madersbacher S
    Eur Urol; 2021 Apr; 79(4):492-504. PubMed ID: 33402296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the addition of vaginal electrical stimulation to transcutaneous tibial nerve electrical stimulation more effective for overactive bladder treatment? A randomized controlled trial.
    Bacchi Ambrosano Giarreta F; Milhem Haddad J; Souza de Carvalho Fusco HC; Chada Baracat E; Casarotto RA; Alves Gonçalves Ferreira E
    Actas Urol Esp (Engl Ed); 2021; 45(1):64-72. PubMed ID: 32660872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of outcome in children and adolescents with overactive bladder treated with parasacral transcutaneous electrical nerve stimulation.
    Hoffmann A; Sampaio C; Nascimento AA; Veiga ML; Barroso U
    J Pediatr Urol; 2018 Feb; 14(1):54.e1-54.e6. PubMed ID: 28974365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of medication for treating overactive bladder in patients with Parkinson's disease: a meta-analysis and systematic review of randomized double-blind placebo-controlled trials.
    Cheng B; Huang S; Huang Q; Zhou Z; Bao Y
    Int Urogynecol J; 2023 Sep; 34(9):2207-2216. PubMed ID: 37052644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome.
    Souto SC; Reis LO; Palma T; Palma P; Denardi F
    World J Urol; 2014 Feb; 32(1):179-84. PubMed ID: 23749315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M; Crampton J
    Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of Kinesio taping and external electrical stimulation in addition to pelvic floor muscle exercise and sole pelvic floor muscle exercise in women with overactive bladder: a randomized controlled study.
    Celenay ST; Karaaslan Y; Coban O; Oskay K
    Disabil Rehabil; 2022 Sep; 44(18):5124-5132. PubMed ID: 34098818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of fesoterodine and tolterodine in patients with overactive bladder.
    Chapple CR; Van Kerrebroeck PE; Jünemann KP; Wang JT; Brodsky M
    BJU Int; 2008 Nov; 102(9):1128-32. PubMed ID: 18647298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical evaluation of the overactive bladder and urgency urinary incontinence association with obstructive sleep apnea syndrome in a relatively young adult male population.
    Tuncer M; Yazici O; Kafkasli A; Sabuncu K; Salepci B; Narter F; Gungor GA; Yucetas U
    Neurourol Urodyn; 2017 Sep; 36(7):1804-1808. PubMed ID: 27921319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
    Sonmez R; Yildiz N; Alkan H
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrical stimulation with non-implanted electrodes for overactive bladder in adults.
    Stewart F; Gameiro OL; El Dib R; Gameiro MO; Kapoor A; Amaro JL
    Cochrane Database Syst Rev; 2016 Apr; 4():CD010098. PubMed ID: 27037009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated bladder training or in combination with other therapies to improve overactive bladder symptoms: a systematic review and meta-analysis of randomized controlled trials.
    Rocha AK; Monteiro S; Campos I; Volpato M; Verleun D; Valim L; Riccetto C; Botelho S
    Braz J Phys Ther; 2024; 28(4):101102. PubMed ID: 39106788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.